Coastline Trust’s Biogen BIIB Stock Holding History

Coastline Trust’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-37	Closed	-$5.66K	–	399
2024 Q4	$5.66K	Sell	37 -3	-8%	-$506	﹤0.01%	377
2024 Q3	$7.75K	Buy	+40	New	+$8.37K	﹤0.01%	395
2018 Q4	–	Sell	-573	Closed	-$202K	–	303
2018 Q3	$202K	Buy	+573	New	+$197K	0.03%	329

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Coastline Trust's BIIB Position: Q1 2025 in Review

Coastline Trust sold out of Biogen (BIIB) in Q1 2025, closing a stake of 37 shares — an estimated $5.66K sold.

Coastline Trust first reported a position in BIIB in Q3 2018 and held it in 3 quarters. The position peaked at $202K in Q3 2018. 883 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

Coastline Trust reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
Coastline Trust sold 37 Biogen shares in Q1 2025, an estimated $5.66K.
Coastline Trust first reported a position in Biogen in Q3 2018 and held it in 3 quarters.
Coastline Trust's Biogen position peaked at $202K in Q3 2018.
883 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Coastline Trust's 13F filing for Q1 2025, filed 28 Apr 2025.